Kronos Worldwide Inc
KRO NYSE Industrial Inorganic Chemicals Financials FY2016βFY2025
What Kronos Worldwide Inc does
No business description yet.
- Legal name
- KRONOS WORLDWIDE INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 9, 2026
- Accession Β· CIK
- 0001104659-26-025219
0001257640
Revenue and margins
Kronos Worldwide Inc had $1.9B of revenue in fiscal 2025, down 1.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$40.4M in fiscal 2025, β2.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Kronos Worldwide Inc returned $23.0M to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Kronos Worldwide Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $406M | $328M | $195M | $107M | $33.2M |
| Debt incl. finance leases | $451M | $425M | $441M | $507M | $557M |
| Net debt / EBITDA | 0.2x | 0.5x | β | 2.2x | 21.8x |
| Debt / equity | 0.5x | 0.4x | 0.5x | 0.6x | 0.7x |
| Interest coverage | 9.5x | 9.4x | β3.3x | 2.9x | β0.7x |
| Current ratio | 4.4x | 3.8x | 3.0x | 2.3x | 2.7x |
| Quick ratio | 2.9x | 1.9x | 1.5x | 0.9x | 1.0x |
| Total assets | $2.0B | $1.9B | $1.8B | $1.9B | $1.8B |
| Total liabilities | $1.1B | $977M | $1.0B | $1.1B | $1.1B |
| Shareholders' equity | $870M | $957M | $808M | $817M | $751M |
| Net debt (β = net cash) | $45.2M | $97.4M | $246M | $401M | $524M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 7 / 9 | 6 / 9 | 6 / 9 | 5 / 9 | 8 / 9 | 4 / 9 | 3 / 9 | 6 / 9 | 5 / 9 |
| Accruals ratio | β3.9% | 5.2% | 0.9% | β3.8% | β1.9% | β4.6% | 1.2% | β2.9% | 0.7% | β6.1% |
| Altman Z'' | 2.14 | 4.53 | 5.11 | 4.19 | 3.90 | 4.39 | 4.51 | 2.86 | 3.01 | 2.25 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.4B | $1.7B | $1.7B | $1.7B | $1.6B | $1.9B | $1.9B | $1.7B | $1.9B | $1.9B |
| Gross profit | $265M | $570M | $562M | $386M | $351M | $446M | $391M | $165M | $359M | $213M |
| Research and development | $13.0M | $18.0M | $16.0M | $17.0M | $16.0M | $17.0M | $15.0M | $18.0M | $14.0M | $16.0M |
| Operating income | $92.9M | $348M | $330M | $146M | $116M | $187M | $160M | β$56.0M | $123M | β$36.5M |
| Interest expense | $20.5M | $19.0M | $19.5M | $18.7M | $19.0M | $19.6M | $16.9M | $17.1M | $42.9M | $53.0M |
| Pretax income | $61.2M | $306M | $294M | $121M | $80.0M | $153M | $134M | β$72.9M | $150M | β$97.4M |
| Income tax | $17.9M | β$48.8M | $88.8M | $34.0M | $16.1M | $40.5M | $29.4M | β$23.8M | $63.4M | $13.5M |
| Net income | $43.3M | $355M | $205M | $87.1M | $63.9M | $113M | $105M | β$49.1M | $86.2M | β$111M |
| Net income to common | β | β | β | $87.1M | $63.9M | $113M | β | β | β | β |
| Diluted EPS | $0.37 | $3.06 | $1.77 | $0.75 | $0.55 | $0.98 | $0.90 | β$0.43 | $0.75 | β$0.96 |
| Diluted shares | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B | 0.00B | 0.12B | 0.12B | 0.12B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $89.6M | $276M | $189M | $160M | $103M | $207M | $81.7M | $5.5M | $72.5M | $2.5M |
| Capital expenditure | $53.0M | $64.3M | $56.3M | $55.1M | $62.8M | $58.6M | $63.2M | $47.4M | $29.5M | $42.9M |
| Free cash flow | $36.6M | $212M | $132M | $105M | $39.7M | $148M | $18.5M | β$41.9M | $43.0M | β$40.4M |
| Depreciation and amortization | $40.5M | $41.2M | $49.7M | $48.1M | $58.1M | $51.3M | $51.7M | $48.6M | $60.4M | $60.5M |
| Share buybacks | β | β | β | $3.0M | $1.0M | $0.2M | $2.3M | $2.9M | β | β |
| Dividends paid | $69.5M | $69.5M | $78.8M | $83.4M | $83.2M | $83.2M | $87.8M | $87.5M | $55.2M | $23.0M |
| Dividends and buybacks | $69.5M | $69.5M | $78.8M | $86.4M | $84.2M | $83.4M | $90.1M | $90.4M | $55.2M | $23.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $50.7M | $322M | $373M | $391M | $355M | $406M | $328M | $195M | $107M | $33.2M |
| Total debt | $339M | $475M | $457M | $446M | $487M | $451M | $425M | $441M | $507M | $557M |
| Current assets | $650M | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B | $1.2B | $1.1B | $1.1B | $995M |
| Current liabilities | $182M | $232M | $233M | $271M | $260M | $289M | $327M | $371M | $477M | $369M |
| Inventory | $344M | $382M | $498M | $503M | $519M | $432M | $609M | $565M | $657M | $629M |
| Property and equipment, net | $434M | $506M | $486M | $491M | $525M | $503M | $485M | $483M | $694M | $724M |
| Goodwill | β | β | β | β | β | β | β | β | $2.6M | $2.6M |
| Total assets | $1.2B | $1.8B | $1.9B | $2.0B | $2.0B | $2.0B | $1.9B | $1.8B | $1.9B | $1.8B |
| Total liabilities | $785M | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B | $977M | $1.0B | $1.1B | $1.1B |
| Shareholders' equity | $395M | $754M | $840M | $816M | $797M | $870M | $957M | $808M | $817M | $751M |
| Margins | ||||||||||
| Gross margin | 19.4% | 32.9% | 33.8% | 22.3% | 21.4% | 23.0% | 20.3% | 9.9% | 19.0% | 11.5% |
| Operating margin | 6.8% | 20.1% | 19.9% | 8.4% | 7.1% | 9.6% | 8.3% | β3.4% | 6.5% | β2.0% |
| EBITDA margin | 9.8% | 22.5% | 22.9% | 11.2% | 10.6% | 12.3% | 10.9% | β0.4% | 9.7% | 1.3% |
| Net margin | 3.2% | 20.5% | 12.3% | 5.0% | 3.9% | 5.8% | 5.4% | β2.9% | 4.6% | β6.0% |
| FCF margin | 2.7% | 12.2% | 8.0% | 6.1% | 2.4% | 7.6% | 1.0% | β2.5% | 2.3% | β2.2% |
| Returns | ||||||||||
| Return on capital | 9.6% | 38.4% | 25.0% | 12.0% | 10.0% | 15.0% | 11.8% | β4.2% | 6.6% | β2.3% |
| Return on capital employed | 9.3% | 21.8% | 19.8% | 8.6% | 6.5% | 10.9% | 9.9% | β3.8% | 8.6% | β2.5% |
| Return on equity | 11.0% | 61.7% | 25.7% | 10.5% | 7.9% | 13.5% | 11.4% | β5.6% | 10.6% | β14.1% |
| Return on assets | 3.7% | 23.6% | 11.0% | 4.5% | 3.2% | 5.6% | 5.3% | β2.6% | 4.6% | β5.9% |
| Return on tangible equity | 11.0% | 47.0% | 24.4% | 10.7% | 8.0% | 13.0% | 10.9% | β6.1% | 10.6% | β14.8% |
| Growth | ||||||||||
| Revenue growth | β | 26.7% | β3.9% | 4.2% | β5.3% | 18.3% | β0.5% | β13.7% | 13.2% | β1.5% |
| Net income growth | β | 718.7% | β42.2% | β57.5% | β26.6% | 76.7% | β7.4% | β147.0% | β | β228.7% |
| EPS growth | β | 727.0% | β42.2% | β57.6% | β26.7% | 78.2% | β8.2% | β147.8% | β | β228.0% |
| FCF growth | β | 478.7% | β37.6% | β20.4% | β62.3% | 272.5% | β87.5% | β326.5% | β | β194.0% |
| Share count change | β | 0.0% | 0.0% | β0.1% | β0.2% | β100.0% | 115,499,900.0% | β0.3% | β0.1% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.2x | 0.4x | 0.2x | 0.3x | 0.8x | 0.2x | 0.5x | β | 2.2x | 21.8x |
| Debt / equity | 0.9x | 0.6x | 0.5x | 0.5x | 0.6x | 0.5x | 0.4x | 0.5x | 0.6x | 0.7x |
| Interest coverage | 4.5x | 18.3x | 16.9x | 7.8x | 6.1x | 9.5x | 9.4x | β3.3x | 2.9x | β0.7x |
| Current ratio | 3.6x | 4.6x | 5.1x | 4.5x | 4.7x | 4.4x | 3.8x | 3.0x | 2.3x | 2.7x |
| Quick ratio | 1.7x | 2.9x | 3.0x | 2.6x | 2.7x | 2.9x | 1.9x | 1.5x | 0.9x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.9% | 3.7% | 3.4% | 3.2% | 3.8% | 3.0% | 3.3% | 2.8% | 1.6% | 2.3% |
| Payouts / FCF | 189.9% | 32.8% | 59.6% | 82.1% | 212.1% | 56.4% | 487.0% | β | 128.4% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 6.0 | 6.0 | 5.0 | 8.0 | 4.0 | 3.0 | 6.0 | 5.0 |
| Altman Z'' | 2.1 | 4.5 | 5.1 | 4.2 | 3.9 | 4.4 | 4.5 | 2.9 | 3.0 | 2.2 |
| Accruals ratio | β3.9% | 5.2% | 0.9% | β3.8% | β1.9% | β4.6% | 1.2% | β2.9% | 0.7% | β6.1% |
Source: SEC EDGAR XBRL filings (CIK 0001257640). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.